Effects of rebamipide on nonsteroidal anti-inflammatory drugs [NSAID]-induced small bowel injury.

Trial Profile

Effects of rebamipide on nonsteroidal anti-inflammatory drugs [NSAID]-induced small bowel injury.

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 01 Apr 2011

At a glance

  • Drugs Rebamipide (Primary)
  • Indications NSAID-induced gastrointestinal damage
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Apr 2011 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 30 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top